Circulating Angiopoietin-1 Is Not a Biomarker of Disease Severity or Prognosis in Pulmonary Hypertension

about

Update on Pulmonary Arterial Hypertension Research: Proceedings from a Meeting of Experts.

P2860

Q46229295-1AA6E20B-B2FF-4D2D-89AA-29CB82A6FAC3

P2860

Circulating Angiopoietin-1 Is Not a Biomarker of Disease Severity or Prognosis in Pulmonary Hypertension

Item

http://www.wikidata.org/entity/Q28109687

description

2016 nî lūn-bûn

@nan

2016 թուականին հրատարակուած գիտական յօդուած

@hyw

2016 թվականին հրատարակված գիտական հոդված

@hy

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

name

Circulating Angiopoietin-1 Is ...... osis in Pulmonary Hypertension

@ast

Circulating Angiopoietin-1 Is ...... osis in Pulmonary Hypertension

@en

Circulating Angiopoietin-1 Is ...... osis in Pulmonary Hypertension

@nl

type

Item

label

Circulating Angiopoietin-1 Is ...... osis in Pulmonary Hypertension

@ast

Circulating Angiopoietin-1 Is ...... osis in Pulmonary Hypertension

@en

Circulating Angiopoietin-1 Is ...... osis in Pulmonary Hypertension

@nl

prefLabel

Circulating Angiopoietin-1 Is ...... osis in Pulmonary Hypertension

@ast

Circulating Angiopoietin-1 Is ...... osis in Pulmonary Hypertension

@en

Circulating Angiopoietin-1 Is ...... osis in Pulmonary Hypertension

@nl

P1476

Circulating Angiopoietin-1 Is ...... osis in Pulmonary Hypertension

@en

P2093

Henning Gall

http://www.w3.org/2001/XMLSchema#string

Manuel Jonas Richter

http://www.w3.org/2001/XMLSchema#string

Svenja Lena Tiede

http://www.w3.org/2001/XMLSchema#string

Thomas Schmidt

http://www.w3.org/2001/XMLSchema#string

P2860

Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis

HUMAN EXPERIMENTATION. CODE OF ETHICS OF THE WORLD MEDICAL ASSOCIATION. DECLARATION OF HELSINKI

Treatment goals of pulmonary hypertension

Requisite role of angiopoietin-1, a ligand for the TIE2 receptor, during embryonic angiogenesis

The antiinflammatory endothelial tyrosine kinase Tie2 interacts with a novel nuclear factor-kappaB inhibitor ABIN-2.

2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS):

Angiopoietin-2 in adults with congenital heart disease and heart failure

Capillary pCO2 helps distinguishing idiopathic pulmonary arterial hypertension from pulmonary hypertension due to heart failure with preserved ejection fraction

Ambrisentan and Tadalafil Up-front Combination Therapy in Scleroderma-associated Pulmonary Arterial Hypertension.

P304

e0165982

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

2718974

http://www.w3.org/2001/XMLSchema#string

P356

10.1371/JOURNAL.PONE.0165982

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

P577

2016-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27802345

http://www.w3.org/2001/XMLSchema#string

P921

arterial hypertension

biomarker

P932

5089726

http://www.w3.org/2001/XMLSchema#string

Circulating Angiopoietin-1 Is Not a Biomarker of Disease Severity or Prognosis in Pulmonary Hypertension

about

P2860

P2860

Circulating Angiopoietin-1 Is Not a Biomarker of Disease Severity or Prognosis in Pulmonary Hypertension

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P3181

P356

P407

P433

P478

P50

P577

P698

P921

P932

P3181

P356

P1433

P1476

P2093

P2860

P304

P31

P3181

P356

P407

P433

P478

P50

P577

P698

P921

P932